NetworkNewsBreaks Archive - Page 1577 of 2183

WednesdayDec 11, 2019 10:56 am

NetworkNewsBreaks – Wisp Resort Integrates InsuraGuest Inc.’s InsurTech Software to Provide Specialized Insurance Coverage

InsuraGuest(R) this morning announced that it is now live with Wisp Resort(R), a four-season ski, golf and mountain recreational destination resort in the mountains of western Maryland. The integration provides specialized insurance coverage that employs InsuraGuest’s proprietary InsurTech software as the first line of defense for the resort property and its guests. InsuraGuest Insurance Agency administers the product for hotels and vacation rental properties throughout the United States through Crum & Forster. “The InsuraGuest product at the Wisp Resort aligns with our vision of delivering online insurance at the point of sale,” Crum & Forster senior vice president, Specialty Business…

WednesdayDec 11, 2019 10:05 am

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Partners with Tango Tango to Offer UV350 Dedicated In-Vehicle Device to US First Responder Customers

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a developer and provider of cellular communications solutions for enterprise workers and first responders, today announced its partnership with Tango Tango, a FirstNet Certified(TM) Push-to-Talk application and communications service provider, to offer the Uniden(R) UV350 dedicated in-vehicle device to its first responder customers in the United States. According to the update, Tango Tango uses advanced networking, mobile and cloud technologies to leverage LTE and WiFi networks and expand the radio coverage and capabilities of public safety agencies. With the Tango Tango application, smart devices can integrate with any existing radio system, creating seamless interoperability…

WednesdayDec 11, 2019 10:01 am

NetworkNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) Secures $3.9 Million in Private Placement

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, today announced closing of its previously disclosed non-brokered private placement. According to the update, MustGrow has closed on an aggregate of 11,139,879 units for gross proceeds of C$3,898,957. The private placement consists of units, with each at a price of C$0.35 and consisting of one common share of the company and one-half of one common share purchase warrant. For a period of 24 months following the closing of the private placement, each full warrant shall entitle the holder to acquire one…

WednesdayDec 11, 2019 9:34 am

NetworkNewsBreaks – Hemptown USA Unveils New CBG-Based Product Line at MJBizCon 2019; Reports 2019 Harvest Results

Hemptown USA, a privately-owned grower of full-spectrum, feminized hemp using premium-seed genetics, on Tuesday announced that the company revealed a portion of its new line of cannabigerol (“CBG”) products at the 2019 MJBizCon in Las Vegas, Nevada. Hemptown USA will be at booth C3831 at the 2019 MJBizCon Conference taking place Dec. 11-13, 2019. The new suite of products includes the Hemptown CBG Tincture, the Hemptown Salve Balm, and an assortment of capsules intended for various uses. The company is also promoting its new Hemptown Chew gum, which contains the highest levels of hemp-derived CBD and CBG cannabinoids currently accessible…

TuesdayDec 10, 2019 2:53 pm

NetworkNewsBreaks – OriginClear Inc. (OCLN) Closed-Loop Wastewater System Facilitates Dealership’s Expansion into Rural Territory

OriginClear (OTC: OCLN), a leading provider of water-treatment solutions, recently proved the value of its closed-loop wastewater system as it empowered an automotive dealership to expand into rural land (http://nnw.fm/7OkUp). An article discussing the company reads, “The OCLN system held up well in comparison to the cost of a commercial-grade septic system. OriginClear’s water system offers a lucrative opportunity to businesses that rely heavily on water, as the system pays for itself in a short period of time by delivering significant water-cost savings. Furthermore, OCLN’s high-grade purification process combats pollution, contamination and corrosion. . . . OriginClear also empowers businesses…

TuesdayDec 10, 2019 2:27 pm

NetworkNewsBreaks – BRK Inc. (BRKK) Announces Strategic Appointment of Former PGA TOUR Pro Rick Pearson as VP of Broadcasting, Professional Athlete Advisory Board Member

BRK Inc. (OTC:BRKK) today announced its strategic hiring of Rick Pearson as its new vice president of broadcasting. Pearson also joins as the third member of the Company’s Professional Athlete Advisory Board. In these roles, Pearson will work with BRK’s chief technology officer in the development of new camera technology for multi-platform broadcasting, as well as initiate business opportunities with the PGA TOUR, PGA OF AMERICA, LPGA and other professional and amateur golf organizations in the USA and internationally. “Rick’s experience in the broadcast industry, coupled with his experience in professional golf, strongly positions him to lead the Company’s directives…

TuesdayDec 10, 2019 1:53 pm

NetworkNewsBreaks – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) Appoints New Chief Executive Officer David Klein

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) today announced the appointment of David Klein as the company's chief executive officer, effective January 14, 2020. Klein served in a number of senior leadership capacities over the past 14 years at Constellation Brands and brings a wealth of expertise to this role. His capabilities include extensive CPG and beverage alcohol industry experience, strong financial orientation, and experience operating in highly regulated markets in the U.S., Canada, Mexico and Europe. "Canopy Growth sits at the forefront of one of the most exciting new market opportunities in our lifetime," Klein said in the news…

TuesdayDec 10, 2019 1:19 pm

NetworkNewsBreaks – Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Commences Dosing in Estrogen Receptor Pilot Study

Eagle Pharmaceuticals (NASDAQ: EGRX) on Monday announced that it has initiated dosing in a pilot clinical study to evaluate the unique characteristics of fulvestrant, EGRX’s product candidate that has the potential to enhance estrogen receptor (“ER”) inhibition and improve patient outcomes. The company will utilize the results of the pilot study to advise the design of the pivotal trial, which Eagle anticipates will commence in 2020. “We are pleased that dosing is underway in our pilot study, and look forward to gathering data to determine the design of our future pivotal study in estrogen receptor positive breast cancer patients. We…

TuesdayDec 10, 2019 1:17 pm

NetworkNewsBreaks – HEXO Corp. (TSX: HEXO) (NYSE: HEXO) Closes $70M Private Placement of Convertible Debentures

HEXO (TSX: HEXO) (NYSE: HEXO) recently announced the closing of its private placement of unsecured convertible debentures for total gross proceeds of $70 million. The group of investors that took part in the offering includes HEXO CEO Sebastien St-Louis, as well as HEXO directors Dr. Michael Munzar, Vincent Chiara, Nathalie Bourque and Adam Miron. Pursuant to the offering, the company issued a total of $70 million principal amount of 8% unsecured convertible debentures maturing on December 5, 2022. The debentures are convertible any time after December 7, 2020 and prior to maturity at a conversion price of $3.16 per share,…

TuesdayDec 10, 2019 12:56 pm

NetworkNewsBreaks – VistaGen Therapeutics, Inc.’s (NASDAQ: VTGN) PH94B Receives FDA Fast Track Designation to Treat Social Anxiety Disorder

VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (“CNS”) diseases and disorders with high unmet need, today announced that it has received Fast Track designation U.S. Food and Drug Administration (“FDA”) for development of the company's PH94B neuroactive nasal spray for on-demand treatment of social anxiety disorder (“SAD”). VistaGen is currently preparing PH94B for phase 3 development. “The FDA's grant of Fast Track designation for development of PH94B for SAD, which to our knowledge is the FDA's first Fast Track designation for a SAD drug candidate, is another important regulatory milestone for…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks